Suppr超能文献

使用抗精神病药物的精神分裂症患者的颞下颌关节紊乱症:一篇讨论文章。

Temporomandibular disorders in patients with schizophrenia using antipsychotic agents: a discussion paper.

作者信息

de Araújo Arão Nogueira, do Nascimento Marion Alves, de Sena Eduardo Pondé, Baptista Abrahão Fontes

机构信息

Postgraduate Program in Interactive Processes of Organs and Systems, Federal University of Bahia, Salvador, Brazil.

Postgraduate Program in Interactive Processes of Organs and Systems, Federal University of Bahia, Salvador, Brazil ; Department of Pharmacology, Institute of Health Sciences, Federal University of Bahia, Salvador, Brazil.

出版信息

Drug Healthc Patient Saf. 2014 Mar 10;6:21-7. doi: 10.2147/DHPS.S57172. eCollection 2014.

Abstract

Patients with psychiatric problems show a tendency to develop temporomandibular disorders (TMD). Particularly, patients with schizophrenia are quite likely to have signs and symptoms of TMD due to the impairment of their oral health, the use of antipsychotic drugs, and other general health problems. In nonschizophrenic populations, TMD have been considered as the main cause of nondental pain in the orofacial region, involving mechanisms associated with changes in masticatory activity at the cortical and neuromuscular levels. Individuals with schizophrenia do not usually complain of pain, and TMD is misdiagnosed in this population. In this paper, we aimed to review the clinical aspects of TMD in people with schizophrenia on antipsychotic drug therapy.

摘要

患有精神疾病的患者有患颞下颌关节紊乱症(TMD)的倾向。特别是,精神分裂症患者很可能由于口腔健康受损、使用抗精神病药物以及其他一般健康问题而出现TMD的体征和症状。在非精神分裂症人群中,TMD被认为是口面部区域非牙源性疼痛的主要原因,涉及与皮质和神经肌肉水平咀嚼活动变化相关的机制。精神分裂症患者通常不会主诉疼痛,因此该人群中的TMD常被误诊。在本文中,我们旨在综述接受抗精神病药物治疗的精神分裂症患者TMD的临床情况。

相似文献

1
Temporomandibular disorders in patients with schizophrenia using antipsychotic agents: a discussion paper.
Drug Healthc Patient Saf. 2014 Mar 10;6:21-7. doi: 10.2147/DHPS.S57172. eCollection 2014.
4
Comorbidity between fibromyalgia and temporomandibular disorders: a systematic review.
Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Jul;128(1):33-42. doi: 10.1016/j.oooo.2019.02.023. Epub 2019 Feb 28.
5
Executive summary of the Diagnostic Criteria for Temporomandibular Disorders for clinical and research applications.
J Am Dent Assoc. 2016 Jun;147(6):438-45. doi: 10.1016/j.adaj.2016.01.007. Epub 2016 Feb 26.
6
[Do temporomandibular disorders really exist?].
Refuat Hapeh Vehashinayim (1993). 2003 Jan;20(1):62-8, 82.
10
Tongue strength, masticatory and swallowing dysfunction in patients with chronic temporomandibular disorder.
Physiol Behav. 2019 Oct 15;210:112616. doi: 10.1016/j.physbeh.2019.112616. Epub 2019 Jul 11.

引用本文的文献

2
Genetically predicted major depression causally increases the risk of temporomandibular joint disorders.
Front Genet. 2024 May 21;15:1395219. doi: 10.3389/fgene.2024.1395219. eCollection 2024.
3
The Effect of Antipsychotics on Cognition in Schizophrenia-A Current Narrative Review.
Brain Sci. 2024 Apr 3;14(4):359. doi: 10.3390/brainsci14040359.
5
Psychometric Properties of the Schizophrenia Oral Health Profile: Preliminary Results.
Int J Environ Res Public Health. 2021 Aug 28;18(17):9090. doi: 10.3390/ijerph18179090.
7
Advancements in temporomandibular joint total joint replacements (TMJR).
Biomed Eng Lett. 2019 Mar 27;9(2):169-179. doi: 10.1007/s13534-019-00105-z. eCollection 2019 May.

本文引用的文献

1
Benefits and limits of anticholinergic use in schizophrenia: focusing on its effect on cognitive function.
Psychiatry Clin Neurosci. 2014 Jan;68(1):37-49. doi: 10.1111/pcn.12088. Epub 2013 Sep 19.
2
Treatment of neurolept-induced tardive dyskinesia.
Neuropsychiatr Dis Treat. 2013;9:1371-80. doi: 10.2147/NDT.S30767. Epub 2013 Sep 16.
3
Conservative approach to tardive dyskinesia-induced neck and upper back pain.
J Am Osteopath Assoc. 2013 Aug;113(8):636-9. doi: 10.7556/jaoa.2013.025.
4
Multisystem dysregulation in painful temporomandibular disorders.
J Pain. 2013 Sep;14(9):983-96. doi: 10.1016/j.jpain.2013.03.011. Epub 2013 May 28.
5
Quality of life and general health in patients with temporomandibular disorders.
Braz Oral Res. 2013 Mar-Apr;27(2):116-21. doi: 10.1590/s1806-83242013005000006. Epub 2013 Mar 1.
6
Antipsychotic agents: efficacy and safety in schizophrenia.
Drug Healthc Patient Saf. 2012;4:173-80. doi: 10.2147/DHPS.S37429. Epub 2012 Nov 29.
7
Pain perception in schizophrenia: evidence of a specific pain response profile.
Pain Med. 2012 Dec;13(12):1571-9. doi: 10.1111/j.1526-4637.2012.01505.x. Epub 2012 Nov 21.
8
Obstructive sleep apnea and severe mental illness: evolution and consequences.
Curr Psychiatry Rep. 2012 Oct;14(5):503-10. doi: 10.1007/s11920-012-0307-6.
9
Antipsychotics, dopamine D₂ receptor occupancy and clinical improvement in schizophrenia: a meta-analysis.
Schizophr Res. 2012 Sep;140(1-3):214-20. doi: 10.1016/j.schres.2012.06.027. Epub 2012 Jul 12.
10
Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
Clin Ther. 2012 Jul;34(7):1487-504. doi: 10.1016/j.clinthera.2012.06.010. Epub 2012 Jun 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验